Group 1 (n = 11 eyes) | Group 2 (n = 14 eyes) | P value | |
---|---|---|---|
Age (years ± SD) | 30.4 ± 8.3 | 32.4 ± 11.5 | 0.62 |
Gender (n) | 0.20 | ||
Male | 6 | 11 | |
Female | 5 | 3 | |
Diagnosis (n) | 0.82 | ||
TB SLC | 6 | 7 | |
MFC | 5 | 7 | |
Laterality (n) | 0.89 | ||
Right eye | 6 | 8 | |
Left eye | 5 | 6 | |
Treatments (n) | |||
Intravitreal DEX | – | 12 | – |
Intravitreal MTX | – | 2 | – |
ATT | 6 | 7 | – |
Oral corticosteroids | 11 | 14 | – |
Initial BCVA (LogMAR units) | 0.41 ± 0.25 | 0.38 ± 0.23 | 0.85 |
Final BCVA (LogMAR units) | 0.32 ± 0.23 | 0.15 ± 0.11 | 0.025 |
(p value)* | (0.01) | (< 0.001) | |
Initial IOP (mm Hg) | 13.6 ± 1.7 | 13.7 ± 2.2 | 0.92 |
Final IOP (mm Hg) | 14.1 ± 2.1 | 14.4 ± 3.8 | 0.82 |
(p value)* | (0.51) | (0.58) |